RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE TREATMENT OF SCHIZOPHRENIA: 3 MONTH PRELIMINARY RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR) IN RUSSIA

被引：0
|
作者：
Lyubov, E. [1 ]
Dzhatdoeva, A. [2 ]
Zhao, Z. [3 ]
Cain, J. [4 ]
机构：
[1] Moscow Inst Psychiat, Moscow, Russia
[2] Janssen Cilag Russia, Moscow, Russia
[3] J&J Worldwide Hlth Econ & Pricing, Raritan, NJ USA
[4] Janssen Pharmaceut, B-2340 Beerse, Belgium
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66903-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A579 / A580
页数：2
相关论文
共 50 条
  • [21] Patient and physician satisfaction with risperidone long-acting injection: 18 months follow-up results front electronic schizophrenia adherence registry (e-STAR) in Belgium
    Jacobs, A.
    Peuskens, J.
    Povey, M.
    van der Veken, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 157 - 157
  • [22] 12-month treatment discontinuation rates in patients with schizophrenia treated with risperidone long acting injection (RLAI): Interim results from the electronic schizophrenia treatment adherence registry project conducted in Spain, Australia and Belgium
    Olivares, J. M.
    Emmerson, B.
    Peuskens, J.
    Diels, J. K.
    Caleo, S.
    Povey, M.
    Lam, A.
    VALUE IN HEALTH, 2007, 10 (03) : A83 - A83
  • [23] Electronic Schizophrenia Treatment Adherence Registry in Latin America (e-STAR): Clinical outcomes of long-acting injectable risperidone in a 2-year follow up
    Apiquian, Rogelio
    Cordoba, Rodrigo
    Louza, Mario
    Fresan, Ana
    SALUD MENTAL, 2013, 36 (01) : 19 - 26
  • [24] Remission in schizophrenia patients treated with long acting risperidone: 12-month results of electronic schizophrenia treatment adherence registry
    Zhao, Z.
    Tuma, I.
    Peuskens, J.
    Pecenak, J.
    Eriksson, L.
    Bork, B.
    Povey, M.
    Lam, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 159 - 160
  • [25] Remission in schizophrenia patients treated with long acting risperidone: 12-month results of electronic schizophrenia treatment adherence registry
    Tuma, Ivan
    Peuskens, Jos
    Pecenak, Jan
    Eriksson, Lars
    Bork, B.
    Povey, Michael
    Lam, Annette
    Zhao, Zhongyun
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 266S - 266S
  • [26] Australian schizophrenic patients treated with risperidone long-acting injection (RLAI): Interim results from the e-STAR study
    Emmerson, B
    Hustig, H
    Lambert, T
    Diels, J
    Jacobs, A
    Methven, C
    VALUE IN HEALTH, 2006, 9 (03) : A64 - A65
  • [27] Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients: results from electronic Schizophrenia Treatment Adherence Registry (e-STAR) and Trial for the Initiation and Maintenance Of REmission in Schizophrenia with risperidone (TIMORES)
    Dubois, Vincent
    Peuskens, Joseph
    Geerts, Paul
    Detraux, Johan
    EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 (01) : 39 - 49
  • [28] The electronic schizophrenia treatment adherence registry - E-STAR: Baseline results for Germany, Spain and Australia
    Rossillon, D
    Caleo, S
    Farmer, D
    Ingham, M
    Jacobs, A
    VALUE IN HEALTH, 2005, 8 (03) : 403 - 403
  • [29] Remission in patients with schizophrenia treated with risperidone long-acting injection:: Results from the e-STAR project in Czech Republic and Slovakia
    Pecenak, J.
    Tuma, I.
    Povey, M.
    Lam, A.
    EUROPEAN PSYCHIATRY, 2008, 23 : S162 - S162
  • [30] Reduction in suicidal ideation, violent behaviour, and self injury after treatment with risperidone long-acting injection (RLAI): 12 month preliminary results from e-STAR project in Czech Republic and Slovakia
    Tuma, I
    Pecenak, J.
    Povey, M.
    Lam, A.
    VALUE IN HEALTH, 2007, 10 (06) : A290 - A290
12345